bullish

ECM Weekly (13 April 2019) - So-Young, Japan Post Trio, Shenwan Hongyuan, Changliao, Uber

729 Views13 Apr 2019 12:37
SUMMARY

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for upcoming IPOs.

This is another busy week in the placement space. Sumeet Singh covered a grand total of six placements.

This week, updates on Japan Post privatization presented an opportunity to set up a trade on Japan Post Holdings (6178 JP) and Japan Post Bank (7182 JP). This came after the Japanese government said that it plans to sell another 1.06bn share of JPH as soon as Sep 2019.

We think that we might see a selldown of JPB shares before Sep and, if that were to happen, JPH could buyback and absorb a big chunk of the government sale of JPH which could be a positive on JPH in the long term. Read more in:

Back in Hong Kong, there was Guotai Junan Securities (H) (2611 HK)'s US$340m placement which was partially upsized to about US$404m. The share price was struggling to hold but still managed to close above its fixed deal price on Friday.

Our idea on Dongzheng Automotive Finance (2718 HK) last week worked out well. It has managed to claw back lost grounds (up about 20% from HK$2.57) to close just 1 cent above its IPO price after a disastrous debut. The name is still fairly liquid for now, traded about US$14m per day.

As for upcoming IPOs, we heard that Duiba Group (1649112D CH) and Viva Biotech (1577881D HK) are pre-marketing for their IPO. There will be a note on Duiba next week while Ke Yan, CFA, FRM has already penned down his early thoughts on Viva Bio in:

We are also hearing that Yunji Inc. (YJ US) has started premarketing for its US IPO while So-Young (SY US) just filed for a US$150 IPO. We think the latter is interesting given that it has already turned profitable and seemed to have found a good niche within the medical aesthetic industry. Read more in:

And, of course, not forgetting that the much-anticipated Uber Technologies (0084207D US) has finally filed for IPO in the US!

Accuracy Rate:

Our overall accuracy rate is 72.4% for IPOs and 63.5% for Placements

(Performance measurement criteria is explained at the end of the note)

New IPO filings

  • Hansoh Pharma (re-filed, Hong Kong)
  • Clarity Medical Group (>US$100m, Hong Kong)
  • So-Young (US$150m, the U.S)

Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.

Source: Aequitas Research, Smartkarma

News on Upcoming IPOs

This week Analysis on Upcoming IPO

NameInsight
Hong Kong
AB InbevAb InBev Asia Pre-IPO - A Brief History of the Asia Pacific Operations - Eeking Out Growth in China
AscentageAscentage Pharma (亚盛医药) IPO: Too Early for an IPO
Ant FinancialAnt Financial IPO Early Thought: Understand Fintech Empire, Growth & Risk Factors
CIMC VehCIMC Vehicle (中集车辆): Market Leader of Semi-Trailers but Little Growth Ahead
ByteDance

ByteDance (字节跳动) IPO: How Jinri Toutiao Paves The Way for a Bigger Empire (Part 1)

ByteDance

ByteDance (字节跳动) IPO: Tiktok the No.1 Short Video App for a Good Reason (Part 2)

East EduChina East Education (中国东方教育) Pre-IPO - The Company Known for Its Culinary School
China TobacChina Tobacco International (IPO): The Monopolist Will Not Recover
China TobacChina Tobacco Intl (HK) IPO: Proxy For the Chinese Cigarette Consumption
ESRESR Cayman Pre-IPO - A Giant in the Making
ESR

ESR Cayman Pre-IPO - Earnings and Segment Analysis

ESR

ESR Cayman Pre-IPO- First Stab at Valuation

Frontage

Frontage (方达控股) IPO: More Disclosure Needed to Understand Moat and Growth Prospect

Frontage

Frontage (方达控股) IPO: Updates from 2018 Numbers

Hujiang Edu

Hujiang Education (沪江教育) Pre-IPO - Spending More than It Earns

Jinxin

Jinxin Fertility (锦欣生殖) Pre-IPO: Strong Foothold in Sichuan but Weak Sentiment for Sector

MicuRxMicuRx Pharma (盟科医药) IPO: Betting on Single Drug in the Not so Attractive Antibiotic Segment
SH Henlius

Shanghai Henlius (复宏汉霖) IPO: Not an Impressive Biosimilar Portfolio

TubatuTubatu Group Pre-IPO - Performing Better than Qeeka but Growing Much Slower, US$1bn a Stretch
TubatuTubatu Group Pre-IPO - Online -> Online + Offline -> Online -> ?
Viva BioViva Biotech (维亚生物) IPO: When CRO Becomes Early Stage Biotech Investor
Viva BioViva Biotech (维亚生物) IPO: Warning Signs from 2018 Numbers (Part 2)
South Korea
KMH ShillaKMH Shilla Leisure IPO Preview (Part 1) - Highly Profitable Operator of Public Golf Courses in Korea
KMH ShillaKMH Shilla Leisure IPO Preview (Part 2) - Valuation Analysis
Plakor

Plakor IPO Preview (Part 1)

ZinusZinus IPO Preview (Part 1) - An Amazing Comeback Story (#1 Mattress Brand on Amazon)
India
Anmol IndAnmol Industries Pre-IPO Quick Take - No Growth, Generous Payments to Founders
Bharat Hotels

Bharat Hotels Pre-IPO - Catching up with Peers

CMS InfoCMS Info Systems Pre-IPO - When a PE Sells to Another PE... Only One Gets the Timing Right
Crystal CropCrystal Crop Protection Pre-IPO - DRHP Raises More Questions than in Answers
Flemingo Flemingo Travel Retail Pre-IPO - Its a Different Business in Every Country
NSENSE IPO Preview- Not Only Fast..its Risky and Expensive
NSENational Stock Exchange Pre-IPO Review - Bigger, Better, Stronger but a Little Too Fast for Some
MazagonMazagon Dock IPO Preview: A Monopoly Submarine Yard in India with Captive Navy Spending
Mrs. BectorMrs. Bectors Food Specialities Pre-IPO Quick Take - Sales for Its Main Segment Have Been Sta

Lodha

Lodha Developers Pre-IPO - Second Time Lucky but Not Really that Much Affordable
LodhaLodha Developers IPO: Presence in Affordable Segment Saves Lodha the Blushes in a Sluggish Mkt
IndiaMartIndiaMART Pre-IPO - Getting and Retaining Subscribers Seems to Be Difficult
PNB MetPNB Metlife Pre-IPO Quick Take - Doesn't Stack up Well Versus Its Larger Peers
Malaysia
QSRQSR Brands Pre-IPO - As Healthy as Fast Food
LeongHupLeong Hup Pre-IPO - Hard to Pinpoint What's Going to Be the Revenue Driver Going Forward
The U.S
YunjiYunji (云集) Pre-IPO Review - Poor Disclosure on Data
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
x